Merck Aktie

84.93 CHF 0.41CHF 0.48%
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>

Aktionärsstruktur

Inhaber in %
Freefloat 99.92
Vanguard Group, Inc. (Subfiler) 8.04
State Street Corp. 4.50
Capital Research & Management Co. (World Investors) 3.14
Vanguard Total Stock Market Index Fund 2.83
BlackRock Institutional Trust Co. NA 2.51
BlackRock Fund Advisors 2.37
Wellington Management Co. LLP 2.26
Vanguard 500 Index Fund 1.99
Geode Capital Management LLC 1.53
Capital Research & Management Co. (International Investors) 1.51
Washington Mutual Investors Fund 1.41
Northern Trust Corp. 1.27
American Funds Income Fund Of America 1.12
Spdr S&p 500 Etf 1.11

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2015 2016 2017 2018 2019
Personal am Ende des Jahres 68'000 68'000 69'000 69'000 0
Umsatz pro Mitarbeiter in Mio. EUR 0.57 0.58 0.58 0.62 0.00

Bilanz (in Mio. EUR) - Aktiva

2015 2016 2017 2018 2019
Summe Umlaufvermögen 29'764 30'614 24'766 25'875 0
Summe Anlagevermögen 71'190 64'930 58'746 51'815 0
Summe Aktiva 101'779 95'377 87'872 82'637 0

Bilanz (in Mio. EUR) - Passiva

2015 2016 2017 2018 2019
Gesamtverschuldung/ -verbindlichkeiten 26'514 24'842 24'410 25'114 0
Summe Fremdkapital 57'012 55'069 53'303 55'755 0
Summe Eigenkapital 44'767 40'308 34'569 26'882 0
Summe Passiva 101'779 95'377 87'872 82'637 0

Adresse

2000 Galloping Hill Road, 07033 Kenilworth
Telefon +1 (908) 740-4000
Internet http://www.merck.com

Management

Chia Lin Wang
CEO-Development Centre
Denise Williams
Vice President
Eric Rubin
VP-Global Clinical Oncology
Frank K. Clyburn
Chief Commercial Officer
Geralyn S. Ritter
Secretary, SVP & Assistant General Counsel
Inge G. Thulin
Independent Director
Jennifer Zachary
General Counsel & Executive Vice President
Julie Louise Gerberding
Chief Patient Officer & EVP-Communication
Kenneth C. Frazier
Chairman, President & Chief Executive Officer
Leslie A. Brun
Lead Independent Director
Luciano Rossetti
SVP-Global Scientific Strategy
Mark Talens
Executive Director-Supply Chain Execution
Mary Ellen Coe
Director
Michael Nally
Chief Marketing Officer
Pamela J. Craig
Independent Director
Patricia Fiorello Russo
Independent Director
Paul B. Rothman
Independent Director
Peter C. Wendell
Independent Director
Peter Dannenbaum
Vice President-Investor Relations
Richard R. DeLuca
Executive Vice President & President-Animal Health
Rita A. Karachun
CAO, Senior Vice President & Global Controller
Robert M. Davis
CFO & Executive Vice President-Global Services
Rochelle B. Lazarus
Independent Director
Roger M. Perlmutter
EVP & President-Merck Research Laboratories
Sahm Nasseri
Director-Global Strategy & Marketing
Sandy Tremps
Vice President-R&D IT CIO
Steven C. Mizell
Chief Human Resources Officer & EVP-Human Resource
Thomas Henry Glocer
Independent Director
Thomas Robert Cech
Independent Director
Wendell P. Weeks
Independent Director

Eintrag hinzufügen

;